Divi’s Laboratories Ltd.

BSE: 532540 NSE: Divi’s Laboratories ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

Divi’s Laboratories Overview:

Stock Symbol in NSEStock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPS
NSE:DIVISLABBSE: 532488₹4,173.00₹109,585.48₹59.19₹70.46
52 Week High52 Week LowDay OpenDay HighDay LowVolumes
₹4,173.55₹2,090.05₹4,052.00₹4,173.55₹4,042.10₹444,505.00
Current Price Fall From 52W high How Near from 52Week Low?Today ChangesDivi's Laboratories Ltd.Outstanding Shares [Cr.]Face valueLast Traded Time
0.01%49.91%143.9026.55₹1.005/10/2021 11:29:51
About

Divi’s Laboratories

Its the Indian No-1 multinational information service and consulting Provider company. Divi’s Laboratories is the Subsidiary Company of TATA Group and it’s founded in 1968.

Divi’s Laboratories Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • Divi’s Laboratories is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2009Mar 2011Mar 2012Mar 2010Mar 2013Mar 2015Mar 2014Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Net Profit4174295333406028527731,1261,0608771,3531,377
EPS in Rs.16.0916.1920.0912.8822.6732.0729.1342.4139.9533.0450.9651.85
Dividend Payout %9%31%32%23%33%31%34%24%25%30%31%31%
Dividend5.026.432.967.489.949.9010.189.999.9115.8016.07
Profit Grouth Rates26.18%24.24%-18.47%12.95%10.22%28.41%32.16%-5.86%-17.26%54.28%1.77%
Avearge Profit Grouth Rates3.86%10.65%11.22%13.92%14.66%16.53%13.73%10.28%14.68%13.51%

Divi’s Laboratories Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Years (CG)Next 10 Years (CG)Next 20 Years (CG)
₹2,594.79₹4,889.55₹17,362.19
₹97.70₹184.11₹653.76
₹1,954.10₹3,682.26₹13,075.23
₹2,442.62₹4,602.82₹16,344.04
₹2,931.15₹5,523.38₹19,612.84
₹3,419.67₹6,443.95₹22,881.65

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 5 Years (CG+5%)Next 10 Years (CG+5%)Next 20 Years (CG+5%)
₹3,218.89₹7,524.51₹41,117.10
₹121.21₹283.33₹653.76
₹2,424.10₹5,666.61₹13,075.23
₹3,030.13₹7,083.26₹16,344.04
₹3,636.15₹8,499.91₹19,612.84
₹4,242.18₹9,916.56₹22,881.65

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

Next 5 Years (CG-5%)Next 10 Years (CG-5%)Next 20 Years (CG-5%)
₹2,071.47₹3,116.20₹7,052.07
₹78.00₹117.34₹265.54
₹1,560.00₹2,346.77₹5,310.82
₹1,950.00₹2,933.46₹6,638.52
₹2,340.00₹3,520.15₹7,966.23
₹2,730.00₹4,106.84₹9,293.93

Divi’s Laboratories Quarterly Result, Date & Street Estimate:

Share NameQuarter ResultsYearStreet EstimatesProfitsGrowth
Divi's Laboratories LtdQ1 Results2021
Divi's Laboratories LtdQ2 Results2021
Divi's Laboratories LtdQ3 Results2021
Divi's Laboratories LtdQ4 Results2021
Divi's Laboratories LtdQ1 Results2020
Divi's Laboratories LtdQ2 Results2020
Divi's Laboratories LtdQ3 Results2020
Divi's Laboratories LtdQ4 Results2020

Fundamental Analysis of Divi’s Laboratories :

Divi’s Laboratories Share Long Term Investment Price Target:

Long Term Investment TagetsPriceQnt.Ratio
Lot-1₹2,910.2220 [1X]
Lot-2₹2,702.3440 [2X]
Lot-3₹2,494.4780 [4X]
Lot-4₹2,286.60180 [8X]

Divi’s Laboratories Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of Divi’s Laboratories

S

  • Strengths Analysis will coming Soon.

W

  • Weakness Analysis will coming Soon.

O

  • Opportunity Analysis will coming Soon.

T

  • Threats Analysis will coming Soon.

Where we can See Divi’s Laboratories in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of Divi’s Laboratories :

Divi’s Laboratories Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price
250S-1250R-1N/A
226S-2226R-2N/A
217S-3217R-3N/A
202S-4202R-4N/A
191S-5191R-5N/A
183S-6183R-6N/A
166S-7166R-7N/A
158S-8158R-8N/A
141S-9141R-9N/A
S-100R-10N/A
S-110R-11N/A
S-120R-12N/A
S-130R-13N/A
S-140R-14N/A
S-150R-15N/A

Divi’s Laboratories Share Today Intraday Price Target:

IntradayTarget Today [Short Selling]IntradayTarget Today [Long Buying]
₹4,295.12₹3,808.88
₹4,347.80₹3,784.57
N/AN/A
N/AN/A

FAQ on Divi’s Laboratories :

Is it Good to Buy Divi’s Laboratories Share?

Yes, Divi’s Laboratories is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is Divi’s Laboratories Debt Free Company?

Divi’s Laboratories is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is Divi’s Laboratories Overvalued?

Currently Divi’s Laboratories is Trading at P/E Ratio which is

Is Divi’s Laboratories Better than Infosys?

Both and working as a

Why Divi’s Laboratories Share Price is Falling?

Do to Covid-19 pandemic Divi’s Laboratories Share drastically fall.

Why Divi’s Laboratories Share Price is Going Up?

Is Divi’s Laboratories Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, Divi’s Laboratories at 20-25 P/E Ration is a excellent buy call for long Term Investment.

Divi’s Laboratories ‘s Products/Projects:

Products/ProjectsDescription/Valuation
A.
B.
C.

IPO, Split, Bonus, Dividend Buyback History:

Divi’s Laboratories First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”78846″

Company Profile:

CEO NameMurali K Divi
CFO Name Kishore Babu
CEO Salary58.8 crore
Company AddressAnnavaram Post, Chippada Village, Bheemunipatnam Mandal, Visakhapatnam, Andhra Pradesh 531163
Contact Number089222 48927
Email Address mail@divislaboratories.com

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.